Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

Goldman Sachs Upgrades Duane Reade

Goldman Sachs adds Duane Reade (DRD) to his

recommended list, up from market outperform. On Friday the company posted third-quarter EPS of $0.27 compared with $0.34 3Q EPS. He sets a conservative 12 to 15-month price target of $40, up 35% from current levels.

Analyst John Heinbockel believes that the drug store chain is capable of nearly doubling its store base, without leaving metro New York during the next five years. He says that, with this expansion, sales and profit will grow by 15% and 20%, respectively. Shares should meaningfully outperform over the next 2-3 years. He notes a recent 20% pullback in the stock creates a compelling entry point. He sees fiscal 2001 EPS of $1.22 and $1.65 in 2002.

blog comments powered by Disqus